https://www.selleckchem.com/pr....oducts/740-y-p-pdgfr
Steroids were administered in 50% of cases. After a mean follow-up of 7.2 years, four patients (16.7%) had a poor kidney outcome end-stage renal disease (n = 3) or a 50% decrease in eGFR from initial values (n = 1). A similar evolution was observed in patients with primitive IgAN. This first case series suggests that IBD-associated IgAN have frequent inflammatory lesions at onset and variable long-term outcome. This first case series suggests that IBD-associated IgAN have frequent inflammatory lesions at onset and vari
Like
Comment
Share
